NGLFINEPharmaceuticals
NGL Fine Chem Ltd — PE Ratio & Valuation Analysis
₹2057.10
-5.32%
Current P/E40.31xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E38.6x4.4% above avg
⚠️
26.9% Premium to Industry
NGLFINE P/E 40.31x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹34.19 | ₹1406 | 41.1x |
| 2024 | ₹66.88 | ₹1811 | 27.1x |
| 2023 | ₹33.18 | ₹2230 | 67.2x |
| 2022 | ₹80.77 | ₹1536 | 19x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding NGL Fine Chem Ltd Valuation
NGL Fine Chem Ltd (NGLFINE) currently trades at 40.31x earnings. The Pharmaceuticals sector average PE is 31.77x. NGLFINE commands a premium, reflecting high growth expectations. Historically, NGLFINE has traded at an average PE of 38.6x — it is currently above that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
7.75%
Dividend Yield
0.13%
More on NGL Fine Chem Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.